Rocco Merolla

1.4k total citations
33 papers, 1000 citations indexed

About

Rocco Merolla is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Rocco Merolla has authored 33 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 14 papers in Pulmonary and Respiratory Medicine and 6 papers in Hepatology. Recurrent topics in Rocco Merolla's work include Respiratory viral infections research (12 papers), Neonatal Respiratory Health Research (8 papers) and Pneumonia and Respiratory Infections (7 papers). Rocco Merolla is often cited by papers focused on Respiratory viral infections research (12 papers), Neonatal Respiratory Health Research (8 papers) and Pneumonia and Respiratory Infections (7 papers). Rocco Merolla collaborates with scholars based in Italy, United States and Sweden. Rocco Merolla's co-authors include James R. Panuska, Giovanni A. Rossi, R Ronchetti, Nancy A. Rebert, Alberto Villani, Marcello Lanari, Stephen Hoffmann, Fabio Midulla, Nick M. Cirino and Maria Cristina Medici and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Rocco Merolla

33 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rocco Merolla Italy	16	632	450	181	180	129	33	1000
E.A.M. Westerbeek Netherlands	15	252 0.4×	220 0.5×	105 0.6×	125 0.7×	76 0.6×	23	929
Avigdor Mandelberg Israel	23	687 1.1×	853 1.9×	119 0.7×	253 1.4×	139 1.1×	47	1.4k
Fernando M. de Benedictis Italy	19	396 0.6×	387 0.9×	130 0.7×	220 1.2×	116 0.9×	48	1.2k
Surendran Thavagnanam Malaysia	17	455 0.7×	506 1.1×	154 0.9×	175 1.0×	124 1.0×	39	1.3k
G Fluge Norway	19	309 0.5×	314 0.7×	39 0.2×	327 1.8×	91 0.7×	57	1.1k
Maria Grazia Capretti Italy	18	483 0.8×	141 0.3×	203 1.1×	91 0.5×	37 0.3×	50	885
I. Dab Belgium	19	253 0.4×	873 1.9×	104 0.6×	330 1.8×	48 0.4×	42	1.2k
Margaret F. Guill United States	16	155 0.2×	821 1.8×	72 0.4×	133 0.7×	55 0.4×	39	1.3k
E Olafsdottir Norway	12	167 0.3×	179 0.4×	49 0.3×	258 1.4×	76 0.6×	25	822
Fügen Çokuğraş Türkiye	15	141 0.2×	130 0.3×	57 0.3×	288 1.6×	89 0.7×	46	765

Countries citing papers authored by Rocco Merolla

Since Specialization

Citations

This map shows the geographic impact of Rocco Merolla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco Merolla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco Merolla more than expected).

Fields of papers citing papers by Rocco Merolla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocco Merolla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco Merolla. The network helps show where Rocco Merolla may publish in the future.

Co-authorship network of co-authors of Rocco Merolla

This figure shows the co-authorship network connecting the top 25 collaborators of Rocco Merolla. A scholar is included among the top collaborators of Rocco Merolla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocco Merolla. Rocco Merolla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aghemo, Alessio, Marcello Persico, Roberta D’Ambrosio, et al.. (2023). Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study. PLoS ONE. 18(2). e0280165–e0280165. 2 indexed citations

Kondili, Loreta A., Massimo Andreoni, Alessio Aghemo, et al.. (2023). Forecasting the long‐term impact of COVID‐19 on hepatitis C elimination plans in Italy: A mathematical modelling approach. Liver International. 43(12). 2615–2624. 1 indexed citations

Stefani, Ambra, Alessandro Tessitore, Nicola Tambasco, et al.. (2022). Criteria for identification of advanced Parkinson’s disease: the results of the Italian subgroup of OBSERVE-PD observational study. BMC Neurology. 22(1). 41–41. 14 indexed citations

Kondili, Loreta A., Massimo Andreoni, A. Albertí, et al.. (2022). A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions. BMC Infectious Diseases. 22(1). 58–58. 7 indexed citations

Kondili, Loreta A., Massimo Andreoni, A. Albertí, et al.. (2021). Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression. Epidemics. 34. 100442–100442. 30 indexed citations

Andreoni, Massimo, Giovanni Di Perri, Marcello Persico, et al.. (2021). Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy. Infectious Diseases and Therapy. 10(2). 763–774. 4 indexed citations

Cutrera, Renato, Andrea Wolfler, Simonetta Picone, et al.. (2019). Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reports. The Italian Journal of Pediatrics/Italian journal of pediatrics. 45(1). 139–139. 14 indexed citations

Fanos, Vassilios, A. Scarcella, Francesca Gallini, et al.. (2009). Respiratory Disorders and Hospitalization Rates During the Second RSV Season in Preterm Infants Who Received Palivizumab Prophylaxis During Their First RSV Season. Journal of Chemotherapy. 21(3). 302–310. 6 indexed citations

Rossi, Giovanni A., Maria Cristina Medici, Maria Cristina Arcangeletti, et al.. (2007). Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics. European Journal of Pediatrics. 166(12). 1267–1272. 74 indexed citations

10.

Rossi, Giovanni A., Maria Cristina Medici, & Rocco Merolla. (2005). Incidence of Respiratory Syncytial Virus Positivity in Young Italian Children Referred to the Emergency Departments for Lower Respiratory Tract Infection over Two Consecutive Epidemic Seasons. Infection. 33(1). 18–24. 15 indexed citations

11.

Iacono, Giuseppe, Rocco Merolla, Domenico D’Amico, et al.. (2005). Gastrointestinal symptoms in infancy: A population-based prospective study. Digestive and Liver Disease. 37(6). 432–438. 147 indexed citations

12.

Fiore, Paolo Del, Elio Castagnola, & Rocco Merolla. (2002). Effect of Nutritional Intervention on Physical Growth in Children at Risk of Malnutrition. 17(3). 179–183. 2 indexed citations

13.

Ronchetti, Maria Paola, Francesco Guglielmi, Rocco Merolla, et al.. (1999). Resistance Patterns of Streptococcus pneumoniae from Children in Central Italy. European Journal of Clinical Microbiology & Infectious Diseases. 18(5). 376–379. 21 indexed citations

14.

Ronchetti, Maria Paola, Rocco Merolla, Francesco Guglielmi, et al.. (1999). Prevalence of mefE, erm and tet(M) genes in Streptococcus pneumoniae strains from central Italy. International Journal of Antimicrobial Agents. 13(1). 29–33. 26 indexed citations

15.

Ronchetti, Maria Paola, et al.. (1998). Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care lefts in a central Italian city. Clinical Microbiology and Infection. 4(11). 622–626. 17 indexed citations

16.

Panuska, James R., Rocco Merolla, Nancy A. Rebert, et al.. (1995). Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.. Journal of Clinical Investigation. 96(5). 2445–2453. 112 indexed citations

17.

Merolla, Rocco, et al.. (1995). Respiratory Syncytial Virus Replication in Human Lung Epithelial Cells: Inhibition by Tumor Necrosis Factor Alpha and Interferon Beta. American Journal of Respiratory and Critical Care Medicine. 152(4). 1358–1366. 44 indexed citations

18.

Midulla, Fabio, Alberto Villani, Rocco Merolla, et al.. (1995). Bronchoalveolar lavage studies in children without parenchymal lung disease: Cellular constituents and protein levels. Pediatric Pulmonology. 20(2). 112–118. 70 indexed citations

19.

Midulla, Fabio, Alberto Villani, James R. Panuska, et al.. (1993). Respiratory Syncytial Virus Lung Infection in Infants: Immunoregulatory Role of Infected Alveolar Macrophages. The Journal of Infectious Diseases. 168(6). 1515–1519. 61 indexed citations

20.

Cirino, Nick M., James R. Panuska, Alberto Villani, et al.. (1993). Restricted replication of respiratory syncytial virus in human alveolar macrophages. Journal of General Virology. 74(8). 1527–1537. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact